Sparrow, US
Abbey Sparrow, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20120131647 | System and Methods for Facilitating Secure Communications on a Website - A system and methods for facilitating secure communications on a website are presented. The system comprising a security server configured to receive a secure message from a creator device is disclosed. The security server encodes the received message and sends the encoded message or a representation of the encoded message for posting on the website so that one or more users of the website have the ability to request that the security server make the message available after the encoded message has been decoded. | 05-24-2012 |
20120317650 | SYSTEM AND METHODS FOR FACILITATING SECURE COMMUNICATIONS ON A WEBSITE - A system and methods for facilitating secure communications on a website are presented. The system comprising a security server configured to receive a secure message from a creator device is disclosed. The security server encodes the received message and sends the encoded message or a representation of the encoded message for posting on the website so that one or more users of the website have the ability to request that the security server make the message available after the encoded message has been decoded. | 12-13-2012 |
20120324217 | SYSTEM AND METHODS FOR FACILITATING SECURE COMMUNICATIONS ON A WEBSITE - A system and methods for facilitating secure communications on a website are presented. The system comprising a security server configured to receive a secure message from a creator device is disclosed. The security server encodes the received message and sends the encoded message or a representation of the encoded message for posting on the website so that one or more users of the website have the ability to request that the security server make the message available after the encoded message has been decoded. | 12-20-2012 |
Carl P. Sparrow, Rahway, NJ US
Patent application number | Description | Published |
---|---|---|
20130189278 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 07-25-2013 |
Carl P. Sparrow, Westfield, NJ US
Patent application number | Description | Published |
---|---|---|
20100040610 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 02-18-2010 |
20100040611 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 02-18-2010 |
20100041102 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 02-18-2010 |
20100136028 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 06-03-2010 |
20100150937 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 06-17-2010 |
20120076799 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 03-29-2012 |
20120077964 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 03-29-2012 |
20120082679 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 04-05-2012 |
20120082680 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 04-05-2012 |
20130115223 | ANTAGONISTS OF PCSK9 - Antagonists of human proprotein convertase subtilisin-kexin type 9 (“PCSK9”) are disclosed. The disclosed antagonists are effective in the inhibition of PCSK9 function and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with PCSK9 activity. The present invention also discloses nucleic acid encoding said antagonists, vectors, host cells, and compositions comprising the antagonists. Methods of making PCSK9-specific antagonists as well as methods of using the antagonists for inhibiting or antagonizing PCSK9 function are also disclosed and form important additional aspects of the present disclosure. | 05-09-2013 |
Christine K. Sparrow, Chagrin Falls, OH US
Patent application number | Description | Published |
---|---|---|
20090235947 | Hair Styling Tool and Method of Using Same - A hair styling tool for creating an uneven part having a base with a handle, a stem and a web portion. First and second tines extend transversely from the web portion, and in the same direction, generally toward the handle. The tines are spaced apart a distance sufficient to lift and separate hair as the tool is moved through hair to form an uneven part. A method for forming an uneven part in hair includes the steps of engaging first and/or second spaced tines of a hair styling tool with a scalp of a person's head at a desired location for the start of the part near the person's face. Moving the hair styling tool toward the desired location of the part end using an alternating pattern to form a desired predetermined uneven hair part. Finally, slightly lifting a handle of the hair styling tool when the second tine has reached the desired location of the part end to separate and capture hair between the first and second tines so that the captured hair may be divided by the tool user. | 09-24-2009 |
Isaac Sparrow, Scotts Valley, CA US
Patent application number | Description | Published |
---|---|---|
20140006420 | PROVIDING STREAMS OF FILTERED PHOTOGRAPHS FOR USER CONSUMPTION | 01-02-2014 |
James A. Sparrow, Irmo, SC US
Patent application number | Description | Published |
---|---|---|
20090252281 | TUBE-IN-TUBE THREADED DASHPOT END PLUG - A nuclear fuel assembly having a tube-in-tube control rod guide tube design that incorporates an end plug that extends axially upward to an elevation above the lower most grid where it is sealed at its upper end to the lower end of the control rod guide tube. The guide tube lower end plug has a threaded recess in its upper surface that mates with a corresponding dashpot end plug threaded extension that is formed as an insert in the lower end of the guide tube. A hole formed through the outer wall of the guide tube end plug at the elevation of the lower portion of the recess provides a positive inspection port for assuring the proper seating of the dashpot. A method of manufacture of such a fuel assembly is also disclosed. | 10-08-2009 |
20130070890 | GROOVED NUCLEAR FUEL ASSEMBLY COMPONENT INSERT - A nuclear fuel assembly component such as a control rod that has a cylindrical insert such as neutron absorbing material that is closely received within a cladding that is sealed at either end with end caps. The cylindrical member has grooves formed in its side wall extending from an upper surface to a lower surface to permit air to escape from the cladding as the cylindrical member is loaded into the cladding during manufacture. | 03-21-2013 |
Janet Sparrow, New York, NY US
Patent application number | Description | Published |
---|---|---|
20140031392 | A NON-RETINOID RBP4 ANTAGONIST FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE - A method for treating bisretinoid-mediated macular degeneration in a mammal afflicted therewith comprising administering to the mammal an effective amount of a compound having the structure: | 01-30-2014 |
Janet R. Sparrow, New York, NY US
Patent application number | Description | Published |
---|---|---|
20150126494 | NON-RETINOID ANTAGONISTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE - A method for treating a disease characterized by excessive lipofuscin accumulation in the retina in mammals afflicted therewith, comprising administering to the mammal an effective amount of a non-retinoid antagonist compound or a pharmaceutically acceptable salt thereof. | 05-07-2015 |
Jim Sparrow, Irmo, SC US
Patent application number | Description | Published |
---|---|---|
20080253496 | NUCLEAR REACTOR CONTROL ROD SPIDER ASSEMBLY - A control rod spider assembly connection between a connecting finger and a rodlet. An upper end plug of the rodlet is secured to the inner bore of the hollow connecting finger with a mating one of a right hand or left hand thread interfacing between the interior of the bore and the circumference of the rodlet. The upper end of the rodlet is captured by a second fastener mechanism having the other of the right hand or the left hand thread. The second fastener mechanism is anchored to one or both of the connecting finger or the upper end plug to secure the connection. | 10-16-2008 |
Mary Ellen Sparrow, Andover, MA US
Patent application number | Description | Published |
---|---|---|
20160101940 | STORAGE MATERIAL HANDLING SYSTEM - A storage fill and retrieval system includes fixed storage locations distributed in a storage space and defining at least one human pick zone having at least one collection tote location, at least one autonomous mobile robot configured for holding and transporting a tote within the storage space and having an end effector arranged for autonomous transfer of the tote between the at least one robot and a tote holding station and a collection tote location, and a storage management system communicably connected to the at least one robot and configured to associate each robot with a human pick zone, wherein the at least one robot is configured to transport the tote to the collection tote location of each associated human pick zone, and wherein each collection tote location is arranged for human picker access and defines an interface between a human picker and the at least one robot. | 04-14-2016 |
Rodney Garland Sparrow, Bolton, MA US
Patent application number | Description | Published |
---|---|---|
20120286486 | Container With Retractable Wheels - A container with retractable wheels. There is a base member having a perimeter shape, and a plurality of retractable wheel assemblies coupled to the base member. The wheel assemblies each have a leg that carries a wheel. The base member defines a cavity for each wheel assembly such that in a stowed position the wheel assemblies fully fit within the cavities and the legs define a portion of the perimeter shape of the base member. | 11-15-2012 |
Stephen Edward Sparrow, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20120055898 | GANTRY WITH SUSPENDING LINKS - The gantry system ( | 03-08-2012 |